Determination of Predictive Factors of Tracheobronchial Prosthesis Removal: Stent Brands are Crucial

Buiret, Guillaume; Colin, Carole; Landry, Guillaume; Poupart, M.; Pignat, J.-C.

doi:10.1177/000348941112000505

Cited by 4 publications

(4 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…24 Contrary to the study by Saad et al, 25 this finding was independent of the benign or malignant nature and precise cause of the stenosis, and independent of the type of prosthesis (for example, non-expandable, expandable covered, or uncovered). Buiret et al 24 reported the stability of each separate brand of prosthesis (the hazard ratio [HR] represents the probability of maintenance of the prosthesis): Ultraflex (HR: 1), covered Wallstent (HR: 2.496), Cook (HR: 8.701), Hanarostent (HR: 9.372), Aboulker (HR: 10.424), Tracheobronxane (HR: 10.626), Novatech Silmet (HR: 17.750), uncovered Wallstent (HR: 57.8), Novatech Y (HR: 88.268), and Rush Y (HR: 122.902). 24 Dasgupta et al 26 assessed 37 patients and reported that the longer a patient has an airway stent fitted, the greater the risk of complications.…”

Section: Predictors Of Stents Removalcontrasting

confidence: 56%

“…19 In a separate series, it was reported that 21 of 48 prosthesis removals were justified by an apparent cure. 23 However, Buiret et al 24 only reported two removals that were justified by an apparent resolution of the stenosis.…”

Section: Haemoptysismentioning

confidence: 99%

“…Buiret et al 24 performed a broad study evaluating several stent brands. It was found that the only significant predictive factor for prosthesis removal was the brand of the prosthesis.…”

Section: Predictors Of Stents Removalmentioning

confidence: 99%

“…Buiret et al 24 reported the stability of each separate brand of prosthesis (the hazard ratio [HR] represents the probability of maintenance of the prosthesis): Ultraflex (HR: 1), covered Wallstent (HR: 2.496), Cook (HR: 8.701), Hanarostent (HR: 9.372), Aboulker (HR: 10.424), Tracheobronxane (HR: 10.626), Novatech Silmet (HR: 17.750), uncovered Wallstent (HR: 57.8), Novatech Y (HR: 88.268), and Rush Y (HR: 122.902). 24 Dasgupta et al 26 assessed 37 patients and reported that the longer a patient has an airway stent fitted, the greater the risk of complications. They noted a complication rate of 0.06 per patient month, with 19 complications in 318 months.…”

Section: Predictors Of Stents Removalmentioning

confidence: 99%

See 3 more Smart Citations

‘No Stent Left Behind’: A Review of Stent Removal and Related Complications

et al. 2017

View full text Add to dashboard Cite

Recently, there have been enormous developments in the endoscopic management of central airway obstruction secondary to benign or malignant processes. Airway stents are an essential component of such management. They provide rapid relief to patients with central airway obstruction. However, like any other foreign object introduced into the body, airway stents have their own complications. These can range from benign, such as increased coughing, to fatal, due to massive haemorrhage. Placement of a stent is a temporary bridging therapy to allow the patient to undergo chemotherapy or radiotherapeutic management. Airway stents should not be left in situ for long, as they themselves can become a disease in patients who already have life-limiting diseases. Hence, the motto at our centre is ‘no stent left behind’, with the only caveat being that they are left behind when the removal itself could cause death. In this paper, we will review the recent literature covering the removal of airway stents. We also describe our experience with airway stents removal. We conclude that efforts should be made to remove all airway stents when the primary disease is controlled. No stent left behind!

show abstract

Section: Predictors Of Stents Removalcontrasting

confidence: 56%

Section: Haemoptysismentioning

confidence: 99%

“…Buiret et al 24 performed a broad study evaluating several stent brands. It was found that the only significant predictive factor for prosthesis removal was the brand of the prosthesis.…”

Section: Predictors Of Stents Removalmentioning

confidence: 99%